Corporate Social Responsibility
Adhere To The Principle Of Sustainable Development To Create A Better Life
Tax policies of Joincare Pharmaceutical Group Industry Co., Ltd.
Published Time：
2024-08-27
Article 1 Purpose
Joincare Pharmaceutical Group Industry Co., Ltd. and its subsidiaries (hereinafter collectively referred to as ： the Group, the entire Group or us) fulfill their tax responsibilities in a responsible manner, implement strict and transparent tax management, establish an effective tax risk management system, and effectively safeguard the needs and long-term interests of all stakeholders. In order to standardize the tax management work of the entire Group, this tax policy (hereinafter referred to as ： this Policy) is specially formulated to achieve our sustainable development and actively fulfill our social responsibilities.
Article 2 Scope of Application
This Policy applies to the entire Group. Each unit of the Group shall fully comply with this Policy when formulating its internal tax management system.
Article 3 Principles
(1) Compliance with Tax Laws and Regulations
We are committed to complying with the letter and spirit of the tax laws and regulations of the countries where the Group operates, including but not limited to the "Tax Collection and Administration Law of the People's Republic of China", the "Implementation Rules of the Tax Collection and Administration Law of the People's Republic of China", the "Enterprise Income Tax Law of the People's Republic of China", the "Implementation Regulations of the Enterprise Income Tax Law of the People's Republic of China", the "Interim Regulations on Value-Added Tax of the People's Republic of China", and the "Implementation Rules of the Interim Regulations on Value-Added Tax of the People's Republic of China".
(2) Advance Planning
We will shift the focus of tax management forward, establish and improve the mechanism for predicting and evaluating tax-related businesses in advance, and strengthen the advance planning and control of tax management.
(3) Reasonable Tax Planning
We are committed to not transferring the created value to low-tax regions, not using tax structures without commercial substance, and adopting the arm's length principle for transfer pricing. Each unit of the Group shall standardize its tax behavior and properly plan its tax schemes to reduce tax risks.
(4) Maintaining Good Tax-Enterprise Relations
Proactively communicate with government tax authorities on major tax-related matters to reach a consensus with the tax authorities and maintain good tax-enterprise relations.
Article 4 Article Management Strategies
(1) Strictly regulate the tax behavior of the Group and its subsidiaries;
(2) Establish and regulate a tax risk management system to effectively prevent tax risks;
(3) Formulate and improve tax risk management objectives;
(4) Establish a tax risk management information system, information communication and processing mechanism covering all aspects of the risk management process and internal control system. Clarify the requirements for tax risk control, maintain good communication, and ensure timely and effective evaluation and monitoring of all types of tax risks.
Article 5 Decision-Making Body
This Policy has been reviewed and approved by the Board of Directors' Sustainable Development Committee. The Board of Directors' Sustainable Development Committee will regularly report to the Board of Directors on the implementation of this Policy and provide suggestions for the Board of Directors' decision-making and supervision.
The Board of Directors' Sustainable Development Committee has full responsibility for implementing, supervising, and regularly reviewing this Policy.
Matters not covered in this Policy shall be handled in accordance with relevant laws, regulations, and normative documents.
This Policy shall come into effect from the date of its promulgation.
Joincare Pharmaceutical Group Industry Co., Ltd.
August 27, 2024
Quick Navigation
+86 755-33268688 | Service Hotline
Official WeChat Official Account
Copyright © 2025 Joincare Pharmaceutical Group Industry Co., Ltd. ALL Rights Reserve.